2023-06-13 12:39:18
Published on :
At the beginning of June in Chicago, during the cancerology congress, a French vaccine was presented to prevent relapses of ENT (otolaryngeal) cancer. A first for the French laboratory Transgene. For Dr. Alessandro Riva, Chairman and CEO of Transgene, guest of France 24, “it is a therapeutic vaccine. It is supposed to delay the relapse of the disease.” Decryption.
1686660547
#Health #French #vaccine #prevent #relapses #ENT #cancers